Kaku, K., Isaka, H., Sakatani, T., & Toyoshima, J. (2019). Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial. Diabetes Obes Metab.

Kaku, Kohei, Hiroyuki Isaka, Taishi Sakatani, ja Junko Toyoshima. "Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial." Diabetes Obes Metab 2019.

Kaku, Kohei, Hiroyuki Isaka, Taishi Sakatani, ja Junko Toyoshima. "Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial." Diabetes Obes Metab 2019.